309 related articles for article (PubMed ID: 16957513)
1. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
[TBL] [Abstract][Full Text] [Related]
2. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
3. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
4. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
8. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
9. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
Zhang J; Xu G
Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
[TBL] [Abstract][Full Text] [Related]
10. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
11. Human colon cancer cells express the functional Fas ligand.
Ding EX; Hizuta A; Morimoto Y; Tanida T; Hongo T; Ishii T; Yamano T; Fujiwara T; Iwagaki H; Tanaka N
Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):13-24. PubMed ID: 9755840
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
13. Regulation of caspase-6 and FLIP by the AMPK family member ARK5.
Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Miyamoto S; Ogura T; Ochiai A; Esumi H
Oncogene; 2004 Sep; 23(42):7067-75. PubMed ID: 15273717
[TBL] [Abstract][Full Text] [Related]
14. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
17. IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro.
Cui LY; Liu SL; Ding Y; Huang DS; Ma RF; Huang WG; Hu BS; Pan QH
Acta Pharmacol Sin; 2007 Oct; 28(10):1671-6. PubMed ID: 17883956
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of recombinant human interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis.
Li CG; Li ML; Shu XH; Liu YJ; Wu WS
Cancer Chemother Pharmacol; 2010 Oct; 66(5):981-6. PubMed ID: 20499068
[TBL] [Abstract][Full Text] [Related]
19. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
[TBL] [Abstract][Full Text] [Related]
20. Tumor escape mechanism involving Fas and Fas-L molecules in human colorectal tumors.
Radfar S; Martin H; Tilkin-Mariame AF
Gastroenterol Clin Biol; 2000 Dec; 24(12):1191-6. PubMed ID: 11173732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
